These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35404441)

  • 1. The Spatial Landscape of Progression and Immunoediting in Primary Melanoma at Single-Cell Resolution.
    Nirmal AJ; Maliga Z; Vallius T; Quattrochi B; Chen AA; Jacobson CA; Pelletier RJ; Yapp C; Arias-Camison R; Chen YA; Lian CG; Murphy GF; Santagata S; Sorger PK
    Cancer Discov; 2022 Jun; 12(6):1518-1541. PubMed ID: 35404441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional profiling of macrophages in situ in metastatic melanoma reveals localization-dependent phenotypes and function.
    Martinek J; Lin J; Kim KI; Wang VG; Wu TC; Chiorazzi M; Boruchov H; Gulati A; Seeniraj S; Sun L; Marches F; Robson P; Rongvaux A; Flavell RA; George J; Chuang JH; Banchereau J; Palucka K
    Cell Rep Med; 2022 May; 3(5):100621. PubMed ID: 35584631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spatially Resolved Transcriptomics Enables Dissection of Genetic Heterogeneity in Stage III Cutaneous Malignant Melanoma.
    Thrane K; Eriksson H; Maaskola J; Hansson J; Lundeberg J
    Cancer Res; 2018 Oct; 78(20):5970-5979. PubMed ID: 30154148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal reaction in cutaneous melanoma.
    Labrousse AL; Ntayi C; Hornebeck W; Bernard P
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):269-75. PubMed ID: 15036266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lessons from cancer immunoediting in cutaneous melanoma.
    Aris M; Barrio MM; Mordoh J
    Clin Dev Immunol; 2012; 2012():192719. PubMed ID: 22924051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma.
    Lepletier A; Madore J; O'Donnell JS; Johnston RL; Li XY; McDonald E; Ahern E; Kuchel A; Eastgate M; Pearson SA; Mallardo D; Ascierto PA; Massi D; Merelli B; Mandala M; Wilmott JS; Menzies AM; Leduc C; Stagg J; Routy B; Long GV; Scolyer RA; Bald T; Waddell N; Dougall WC; Teng MWL; Smyth MJ
    Clin Cancer Res; 2020 Jul; 26(14):3671-3681. PubMed ID: 32345648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer.
    Lin JR; Wang S; Coy S; Chen YA; Yapp C; Tyler M; Nariya MK; Heiser CN; Lau KS; Santagata S; Sorger PK
    Cell; 2023 Jan; 186(2):363-381.e19. PubMed ID: 36669472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells.
    Tucci M; Passarelli A; Mannavola F; Felici C; Stucci LS; Cives M; Silvestris F
    Front Oncol; 2019; 9():1148. PubMed ID: 31750245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cilium depletion typifies cutaneous melanoma in situ and malignant melanoma.
    Kim J; Dabiri S; Seeley ES
    PLoS One; 2011; 6(11):e27410. PubMed ID: 22096570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OMIC signatures to understand cancer immunosurveillance and immunoediting: Melanoma and immune cells interplay in immunotherapy.
    León-Letelier RA; Bonifaz LC; Fuentes-Pananá EM
    J Leukoc Biol; 2019 May; 105(5):915-933. PubMed ID: 30698862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclo-oxygenase-2 in macrophages associated with cutaneous melanoma at different stages of progression.
    Bianchini F; Massi D; Marconi C; Franchi A; Baroni G; Santucci M; Mannini A; Mugnai G; Calorini L
    Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):320-8. PubMed ID: 17499752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP18 is crucial for IFN-γ-mediated inhibition of B16 melanoma tumorigenesis and antitumor immunity.
    Hong B; Li H; Lu Y; Zhang M; Zheng Y; Qian J; Yi Q
    Mol Cancer; 2014 May; 13():132. PubMed ID: 24884733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.
    Roncati L
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):341-343. PubMed ID: 30665488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paracrine Activin-A Signaling Promotes Melanoma Growth and Metastasis through Immune Evasion.
    Donovan P; Dubey OA; Kallioinen S; Rogers KW; Muehlethaler K; Müller P; Rimoldi D; Constam DB
    J Invest Dermatol; 2017 Dec; 137(12):2578-2587. PubMed ID: 28844941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel immune signatures associated with dysplastic naevi and primary cutaneous melanoma in human skin.
    Yan BY; Garcet S; Gulati N; Kiecker F; Fuentes-Duculan J; Gilleaudeau P; Sullivan-Whalen M; Shemer A; Mitsui H; Krueger JG
    Exp Dermatol; 2019 Jan; 28(1):35-44. PubMed ID: 30326165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell Secretome.
    Vescovi R; Monti M; Moratto D; Paolini L; Consoli F; Benerini L; Melocchi L; Calza S; Chiudinelli M; Rossi G; Bugatti M; Maio M; Fonsatti E; Farisoglio C; Simbolo M; Almici C; Verardi R; Scarpa A; Bergese P; Manganoni A; Facchetti F; Vermi W
    Cancer Immunol Res; 2019 Jan; 7(1):12-28. PubMed ID: 30401679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response against human primary malignant melanoma: a distinct cytokine mRNA profile associated with spontaneous regression.
    Wagner SN; Schultewolter T; Wagner C; Briedigkeit L; Becker JC; Kwasnicka HM; Goos M
    Lab Invest; 1998 May; 78(5):541-50. PubMed ID: 9605179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody targeting tumor-derived soluble NKG2D ligand sMIC reprograms NK cell homeostatic survival and function and enhances melanoma response to PDL1 blockade therapy.
    Basher F; Dhar P; Wang X; Wainwright DA; Zhang B; Sosman J; Ji Z; Wu JD
    J Hematol Oncol; 2020 Jun; 13(1):74. PubMed ID: 32517713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10.
    Michielon E; López González M; Burm JLA; Waaijman T; Jordanova ES; de Gruijl TD; Gibbs S
    Cancer Immunol Immunother; 2020 Nov; 69(11):2319-2331. PubMed ID: 32507967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDL1 expression in desmoplastic melanoma is associated with tumor aggressiveness and progression.
    Kraft S; Fernandez-Figueras MT; Richarz NA; Flaherty KT; Hoang MP
    J Am Acad Dermatol; 2017 Sep; 77(3):534-542. PubMed ID: 28728868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.